CVS Health beats quarterly profit estimates as pharmacy services drive growth
CVS Health beat profit estimates on Tuesday as pharmacy gains offset rising medical costs. The firm maintained its 2026 outlook after a 2025 restructuring.
Insights:
CVS Health Corporation reported a decline in its fourth-quarter adjusted profit to $1.09 per share today, yet the result surpassed the Wall Street average estimate of $0.99. The earnings beat, announced on February 10, 2026, in the US 
US, was driven by significant strength in its pharmacy benefit unit and an increase in prescription volume. Total revenue for the quarter rose to $105.7 billion, reflecting a 6.3 percent increase in prescriptions filled across the company's network.
US, was driven by significant strength in its pharmacy benefit unit and an increase in prescription volume. Total revenue for the quarter rose to $105.7 billion, reflecting a 6.3 percent increase in prescriptions filled across the company's network.The performance of CVS Caremark, the company's pharmacy benefit manager, played a primary role in the quarterly results alongside the Aetna insurance segment. This growth in volume and scale suggests a potential shift in the company's recent multi-quarter performance. Despite the quarterly beat, CVS Health maintained its full-year 2026 adjusted earnings per share guidance, leaving the forecast unchanged as the company navigates the broader healthcare landscape.
